DC Chemicals

All products / DC22800

ML-210
CAT. NO. DC22800

ML-210

Pack sizes and prices

Pack sizePrice
25 mg$200 USDRequest a quote →
100 mg$550 USDRequest a quote →
250 mg$950 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

ML-210,the most potent compound in the nitroisoxazole series, is a selective covalent inhibitor of glutathione peroxidase 4 (GPX4) by binding the selenocysteine residue[1]. ML-210 has IC50s of 71 nM, 272 nM and 107nM for BJeLR (HRASV12), BJeH-LT (without HRASV12) and DRD cell lines, respectively[2].

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC22800
Product nameML-210
CAS1360705-96-9
Molecular formulaC22H20Cl2N4O4
Molecular weight475.32460308075
Purity>98%
SMILESClC1=CC=C(C(N2CCN(C(C3=NOC(C)=C3[N+]([O-])=O)=O)CC2)C2=CC=C(Cl)C=C2)C=C1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — ML-210 (DC22800)

Source references

[1]. John K. Eaton, et al. Targeting a Therapy-Resistant Cancer Cell State Using Masked Electrophiles as GPX4 Inhibitors. Biorxiv. 2018. [2]. Weïwer M, et al. Development of small-molecule probes that selectively kill cells induced to express mutant RAS. Bioorg Med Chem Lett. 2012 Feb 15;22(4):1822-6.

Related research products